Researchers are excited about this new drug, a innovative dual agonist showing remarkable data in initial trials for weight reduction . It works by impacting both systems: GLP-1 and GIP, which , when https://neillgus912488.bluxeblog.com/73160808/a-new-possibility-for-body-loss